Lataa...
HBV Pre-S1-Derived Myristoylated Peptide (Myr47): Identification of the Inhibitory Activity on the Cellular Uptake of Lipid Nanoparticles
The Myr47 lipopeptide, consisting of hepatitis B virus (HBV) pre-S1 domain (myristoylated 2–48 peptide), is an effective commercialized anti-HBV drug that prevents the interaction of HBV with sodium taurocholate cotransporting polypeptide (NTCP) on human hepatocytes, an activity which requires both...
Tallennettuna:
| Julkaisussa: | Viruses |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8157113/ https://ncbi.nlm.nih.gov/pubmed/34067884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13050929 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|